TrialHuman vaccines & immunotherapeutics2024

Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers.

Dipesh Tamrakar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.